Riffyn, a cloud-based platform that gives customers the power to answer questions of cause-and-effect across traditional silos of team, place and discipline, today announced it has been recognized in Gartner, Inc.’s “Cool Vendors in R&D Manufacturing, 2017” report published on May 11, 2017. The five vendors named in the report represent many “first of its kind” companies at the intersection of science, engineering, laboratories, and product innovation.
Riffyn, a provider of visual design and data analytics software, announces the formation of a multiyear partnership with Novozymes to deploy and develop Riffyn’s ground-breaking cloud-based software for experiment design and data analytics. Riffyn’s Software-as-a-Service (SaaS) will be implemented progressively across Novozymes’ 1000-person global R&D organization to help support accelerated product development.
Riffyn today announced that Jean-Claude Calegari has joined the company as Vice President of Operations and Finance.
Riffyn announced today the launch of its cloud-based research process design software at the SynBioBeta SF 2016 conference.
Riffyn, a developer of cloud-based software for research and development, today announced that Dr. Tom Treynor has joined the company as Vice President of Product Development and Application Support.
OAKLAND - July 6, 2016 - Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software. The investment brings Riffyn’s funding to $4.6M including lead investments from Bioeconomy Capital and O’Reilly Alphatech Ventures (OATV). Riffyn’s product delivers a step-change in the pace and quality of research and development in the life science, chemical and food industries – supporting organizations from early-stage discovery to manufacturing development and pre-clinical trials.
OAKLAND - September 9, 2015 - Riffyn, Inc. announced the upcoming beta launch of its experimental design software for quality and collaboration in life science, chemical and materials R&D. Registration for Riffyn’s beta launch is open until September 14th.
OAKLAND—November 17, 2014—Riffyn, Inc. has raised $1.8 million in a Seed financing round led by O’Reilly AlphaTech Ventures, with additional investments from Bioeconomy Capital and others.